WASHINGTON (dpa-AFX) - Below are the earnings highlights for Biomarin
Pharmaceutical Inc. (BMRN):

Earnings: $40.38 million in Q3 vs. -$6.65 million in the same period last year.
EPS: $0.21 in Q3 vs. -$0.04 in the same period last year.
Excluding items, Biomarin Pharmaceutical Inc. reported adjusted earnings of
$89.5 million or $0.46 per share for the period.

Analysts projected $0.22 per share
Revenue: $581.33 million in Q3 vs. $505.34 million in the same period last year.


Copyright(c) 2023 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX